HIV–host cell interactions

SK Masenga, BC Mweene, E Luwaya, L Muchaili… - Cells, 2023 - mdpi.com
The development of antiretroviral drugs (ARVs) was a great milestone in the management of
HIV infection. ARVs suppress viral activity in the host cell, thus minimizing injury to the cells …

The initial interplay between HIV and mucosal innate immunity

V Caputo, M Libera, S Sisti, B Giuliani… - Frontiers in …, 2023 - frontiersin.org
Human Immunodeficiency Virus (HIV) is still one of the major global health issues, and
despite significant efforts that have been put into studying the pathogenesis of HIV infection …

Immune responses in controllers of HIV infection

AK Kwaa, JN Blankson - Annual Review of Immunology, 2023 - annualreviews.org
Elite controllers are a heterogeneous group of people living with HIV who control viral
replication without antiretroviral therapy. There is substantial evidence that at least some …

Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure

R Schober, B Brandus, T Laeremans… - Journal of Translational …, 2023 - Springer
Background Combination antiretroviral therapy (cART) has dramatically extended the life
expectancy of people living with HIV-1 and improved their quality of life. There is …

Cellular and molecular insights into incomplete immune recovery in HIV/AIDS patients

L Yan, K Xu, Q Xiao, L Tuo, T Luo, S Wang… - Frontiers in …, 2023 - frontiersin.org
Highly active antiretroviral therapy (ART) can effectively inhibit virus replication and restore
immune function in most people living with human immunodeficiency virus (HIV). However …

When Bacteria and Viruses Collide: A Tale of Chlamydia trachomatis and Sexually Transmitted Viruses

E Ghasemian, E Harding-Esch, D Mabey, MJ Holland - Viruses, 2023 - mdpi.com
The global incidence of sexually transmitted infections (STIs) remains high, with the World
Health Organization (WHO) estimating that over 1 million people acquire STIs daily. STIs …

MiR-155 Negatively Regulates Anti-Viral Innate Responses among HIV-Infected Progressors

P Pawar, J Gokavi, S Wakhare, R Bagul, U Ghule… - Viruses, 2023 - mdpi.com
HIV infection impairs host immunity, leading to progressive disease. An anti-retroviral
treatment efficiently controls viremia but cannot completely restore the immune dysfunction …

Extracellular Vesicle-Based SARS-CoV-2 Vaccine

Y Matsuzaka, R Yashiro - Vaccines, 2023 - mdpi.com
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines.
Despite several issues concerning storage, stability, effective period, and side effects, viral …

[PDF][PDF] Adherence to antiretroviral therapy, CD4 count, viral load and opportunistic infections in people with HIV/AIDS: a cross-sectional study

N Nursalam, T Sukartini, M Misutarno… - Jurnal Ners, 2024 - e-journal.unair.ac.id
Introduction: Globally, antiretroviral therapy (ART) has been successful in reducing the death
rate due to human immunodeficiency virus (HIV). Different conditions in Indonesia mean the …

[HTML][HTML] Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection

MWY Choi, CA Isidoro, A Gillgrass - Current Opinion in Virology, 2024 - Elsevier
Human immunodeficiency virus-1 remains a major global health threat. Since the virus is
often transmitted through sexual intercourse and women account for the majority of new …